top of page


Welcome to Pharmchem Technical Services Pty Ltd (PTS), a leading boutique consultancy in the pharmaceutical and life science industries. Established in 1991 and based in Australia, we have been providing independent, expert advice to over 350 companies across Australia, North & South America, Europe, South Africa, China, and the Asia-Pacific region. Our mission is to offer tailored, professional, and independent consultancy services that address the unique needs of each client in the pharmaceutical and related biotech industries.

Our Tests

Dr. Philip Marshall - Founder and Director

The Founder and Director, Dr. Philip Marshall, BSc (Hons) PhD FRACI CChem, has over 40 years of domestic and international experience in the pharmaceutical and health sectors. Dr. Marshall has held senior executive positions in scientific affairs, quality assurance, compliance, research and development, drug discovery, manufacturing, clinical research, and IP management with major pharmaceutical companies. In addition, Dr. Marshall has a strong background in patent-related matters, making him a valuable asset to legal firms requiring assistance with investigational work, case development, and the production of relevant documentation. Over the past three decades, he has served as an independent Expert Witness in numerous Australian and international court matters involving IP litigation.

Dr Philip Marshall.png

CV Summary

Dr. Philip Andrew Marshall is a distinguished scientist with over 40 years of experience in the pharmaceutical and life sciences industry. Recognized as an international expert in pharmaceutical sciences and medicinal chemistry, he holds a BSc (Hons) and a PhD in Chemistry. With esteemed professional affiliations such as Fellow of the Royal Australian Chemical Institute (FRACI) and Chartered Chemist (CChem), Dr. Marshall's expansive expertise is demonstrated across various aspects of the field.

Dr. Marshall has proudly served as the General Manager of Scientific Affairs for Australia's largest contract and generic manufacturer of pharmaceuticals. In this capacity, he supervised the quality and regulatory compliance of a wide range of products, including high-risk sterile, parenteral products, high potency products, topicals, solid, semi-solid, and liquid oral dosage forms, and complementary medicines.

With a deep understanding of compliance auditing, Dr. Marshall has expertly navigated Good Manufacturing Practices (GMP), Good Laboratory (Control) Practices (GLP), Good Clinical (Research) Practices (GCP), and pharmacovigilance (PhV) regulations in accordance with PIC/S, Australian (TGA), EU, FDA, and WHO guidelines.

Dr Marshall is a current director of Filamon ( a clinical drug development company, Sunscreen Safety Testing Laboratory (SSTL) and a former director and Chairman of Oncology Research International Limited (ORIL).

In summary, Dr. Philip Andrew Marshall is a highly experienced and respected chemist with an extensive background in the pharmaceutical and life sciences industry. As an acknowledged international expert, his unwavering commitment to research, compliance, collaboration, and excellence has significantly impacted the field and future of drug discovery, development and commercialisation.

bottom of page